SPRY
ARS Pharmaceuticals Inc.
$10.24
-$0.98(-8.73%)
57
Overall
50
Value
75
Tech
47
Quality
Market Cap
$888.65M
Volume
2.52M
52W Range
$6.66 - $18.90
Target Price
$26.80
Company Overview
| Mkt Cap | $888.65M | Price | $10.24 |
| Volume | 2.52M | Change | -8.73% |
| P/E Ratio | 111.1 | Open | $11.28 |
| Revenue | $89.1M | Prev Close | $11.22 |
| Net Income | $8.0M | 52W Range | $6.66 - $18.90 |
| Div Yield | N/A | Target | $26.80 |
| Overall | 57 | Value | 50 |
| Quality | 47 | Technical | 75 |
No chart data available
About ARS Pharmaceuticals Inc.
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for severe allergic reactions. The company is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for rescue medication for people with Type I severe allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. The company was founded in 2015 and is headquartered in San Diego, California.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SPRY | $10.24 | -8.7% | 2.52M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get ARS Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW